<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Emerging Infect. Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">17080581</article-id>
      <article-id pub-id-type="pmc">3373081</article-id>
      <article-id pub-id-type="publisher-id">05-0765</article-id>
      <article-id pub-id-type="doi">10.3201/eid1202.050765</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Letter</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>Borrelia burgdorferi</italic> and <italic>Anaplasma phagocytophilum</italic> Coinfection</article-title>
        <alt-title alt-title-type="running-head"><italic>Borrelia burgdorferi</italic> and <italic>Anaplasma phagocytophilum</italic> Coinfection</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Loebermann</surname>
            <given-names>Micha</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fingerle</surname>
            <given-names>Volker</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lademann</surname>
            <given-names>Matthias</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fritzsche</surname>
            <given-names>Carlos</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Reisinger</surname>
            <given-names>Emil C.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <aff id="aff1"><label>*</label>University of Rostock Medical School, Rostock, Germany;</aff>
        <aff id="aff2"><label>&#x2020;</label>Ludwig-Maximilian-Universit&#xE4;t M&#xFC;nchen, Munich, Germany</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Emil C. Reisinger, Division for Tropical Medicine and Infectious Diseases, Department of Medicine, University of Rostock Medical School, Ernst-Heydemann-Str 6, D-18057 Rostock, Germany; fax: 49-381-494-7509; email: <email xlink:href="emil.reisinger@medizin.uni-rostock.de">emil.reisinger@medizin.uni-rostock.de</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2006</year>
      </pub-date>
      <volume>12</volume>
      <issue>2</issue>
      <fpage>353</fpage>
      <lpage>355</lpage>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>ehrlichiosis</kwd>
        <kwd>borreliosis</kwd>
        <kwd>anaplasma</kwd>
        <kwd>coinfection</kwd>
        <kwd>letter</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> In central Europe, <italic>Anaplasma phagocytophilum</italic> and <italic>Borrelia burgdorferi</italic> are transmitted by the hard tick <italic>Ixodes ricinus</italic> (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>). Acute human granulocytic ehrlichiosis (HGE) caused by <italic>A. phagocytophilum</italic> has rarely been documented in Europe (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). Typical symptoms include fever, headache, myalgia, leukopenia, thrombocytopenia, and abnormal liver function test results. The serologic prevalence ranges from 1.9% to 14% in Germany (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>), while clinically apparent infections of HGE have not been reported.</p>
    <p>Acute Lyme borreliosis in Europe is associated with erythema migrans (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>), recognized in up to 90% of patients (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). Erythema migrans may be accompanied by systemic symptoms such as fever, fatigue, myalgia, arthralgia, headache, or stiff neck (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref><italic>,</italic><xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). In southern Germany, an incidence of 111 per 100,000 inhabitants has been reported (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>).</p>
    <p>A 60-year-old woman from northern Germany was admitted with temperature of &lt;40&#xB0;C, headache, myalgia, and generalized weakness that had begun 6 days earlier. She had noticed an erythema migrans on her right thigh 4 days before she sought treatment. At admission, a tender, 5 &#xD7; 8 cm rash and a central papule were seen, but without central clearing. The clinical examination was otherwise normal. Three weeks earlier she had been on a trekking tour in Austria and Slovenia but had not been aware of any tick bites.</p>
    <p>The leukocyte count was 3,030/&#x3BC;L (normal 4,000&#x2013;9,000), with 65% neutrophils, 24% lymphocytes, 10% monocytes, and 1% lymphoid cells. The following results were observed: platelets 127,000/&#x3BC;L (normal 150,000&#x2013;450,000), aspartate aminotransferase 108 U/L (normal &lt;31), alanine aminotransferase 154 U/L (normal &lt;34), gamma-glutamyl transferase 98 U/L (normal &lt;38), lactate dehydrogenase 317 U/L (normal &lt;247), alkaline phosphatase 314 U/L (normal &lt;237), direct bilirubin 4.7 &#x3BC;mol/L (normal &lt;3.4), C-reactive protein 132 mg/L (normal &lt;5), and neopterin 30 nmol/L (normal &lt;10). All other routine laboratory parameters were normal.</p>
    <p>May-Gr&#xFC;nwald-Giemsa (Fluke, Neu Ulm, Germany)&#x2013;stained whole-blood smears did not show <italic>Anaplasma</italic> initially and during follow-up. On admission serum antibody tests were negative for <italic>A. phagocytophilum</italic>, <italic>B. burgdorferi</italic>, hepatitis A, B, and C, human herpes virus 6, herpes simplex virus 1 and 2, Epstein-Barr virus, cytomegalovirus, and tickborne encephalitis virus. Because Lyme borreliosis and possible HGE were suspected, the patient was treated with oral doxycycline 200 mg once daily for 3 weeks. Within 4 days after initiation of treatment, the patient recovered completely; thrombocytes and leukocytes had normalized. Liver enzyme levels were still elevated but had normalized at a follow-up examination 28 days later.</p>
    <p>Four days after the initial examination, results for <italic>Borrelia</italic>-specific immunoglobulin M (IgM) antibodies were positive, while results for IgG antibodies remained negative (<xref ref-type="table" rid="T1">Table</xref>). Four weeks after the onset of symptoms, a test for <italic>A. phagocytophilum</italic>&#x2013;specific IgM antibodies was positive and IgG was negative thereafter (<xref ref-type="table" rid="T1">Table</xref>). An initial EDTA blood sample that was stored frozen and examined retrospectively as well as follow-up EDTA blood samples were negative for <italic>A. phagocytophilum</italic> in a polymerase chain reaction (PCR) assay.</p>
    <table-wrap id="T1" position="float">
      <label>Table</label>
      <caption>
        <title>Results of serologic tests at diagnosis and during follow-up*</title>
      </caption>
      <table frame="hsides" rules="groups">
        <col width="92" span="1"/>
        <col width="67" span="1"/>
        <col width="67" span="1"/>
        <col width="51" span="1"/>
        <col width="47" span="1"/>
        <col width="54" span="1"/>
        <col width="54" span="1"/>
        <thead>
          <tr>
            <th rowspan="2" valign="bottom" align="left" scope="col" colspan="1">Time (d) after onset of symptoms</th>
            <th valign="bottom" colspan="2" align="center" scope="colgroup" rowspan="1"><italic>Anaplasma</italic> (<italic>Ehrlichia</italic>) <italic>phagocytophilum</italic> (IFA)&#x2020;<hr/></th>
            <th valign="bottom" colspan="2" align="center" scope="colgroup" rowspan="1"><italic>Borrelia burgdorferi</italic> (ELISA)&#x2021;<hr/></th>
            <th valign="bottom" colspan="2" align="center" scope="colgroup" rowspan="1"><italic>Borrelia burgdorferi</italic> (Immunoblot)&#xA7;<hr/></th>
          </tr>
          <tr>
            <th valign="bottom" colspan="1" align="center" scope="colgroup" rowspan="1">IgM</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">IgG</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">IgM</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">IgG</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">IgM</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">IgG</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">6</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Negative (&lt;1:20)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Negative (&lt;1:32)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Negative</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Negative</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Negative</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Negative</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">10</td>
            <td valign="top" align="center" rowspan="1" colspan="1">ND</td>
            <td valign="top" align="center" rowspan="1" colspan="1">ND</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Positive</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Negative</td>
            <td valign="top" align="center" rowspan="1" colspan="1">ND</td>
            <td valign="top" align="center" rowspan="1" colspan="1">ND</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">28</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Positive (1:40)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Negative (1:32)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Positive</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Negative</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Positive</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Negative</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">107</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Positive (1:20)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Negative (&lt;1:32)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Positive</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Negative</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Positive</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Negative</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">380</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Negative (&lt;1:20)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Negative (&lt;1:32)</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Equivocal</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Negative</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Positive</td>
            <td valign="top" align="center" rowspan="1" colspan="1">Negative</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <p>*Symptoms (fever, headache, myalgia) started 6 days before presentation. IFA, immunofluorescent assay; ELISA, enzyme-linked immunosorbent assay; Ig, immunoglobulin; ND, not done.&#x2028;&#x2020;Genzyme Virotech, Germany. Positive titers: IgM &gt;1:20, IgG &gt;1:64.&#x2028;&#x2021;Behring, Germany.&#x2028;&#xA7;In-house Immunoblot, Max von Pettenkofer-Institut, Munich, Germany.</p>
      </table-wrap-foot>
    </table-wrap>
    <p>One year after initial examination, results for <italic>Borrelia</italic>-specific IgM antibodies were positive and results for <italic>A. phagocytophilum</italic>-specific antibodies were negative (<xref ref-type="table" rid="T1">Table</xref>). Although HGE has not been reported in Germany, a coinfection with <italic>B. burgdorferi</italic> and <italic>A. phagocytophilum</italic> should be considered in patients with erythema migrans and atypical changes for Lyme borreliosis such as fever, leukopenia, thrombocytopenia, and elevated liver function test results.</p>
    <p>The patient had traveled to an area where both tickborne pathogens, <italic>A. phagocytophilum</italic> and <italic>B. burgdorferi</italic>, were endemic. Erythema migrans and antibody follow up suggested Lyme borreliosis. High fever, leukopenia, thrombocytopenia, and elevated liver enzyme levels indicated HGE. <italic>Anaplasma</italic> PCR was negative, possibly because blood samples were tested retrospectively after 3 months of storage at &#x2013;20&#xB0;C. However, a commercially available indirect fluorescent antibody assay was able to demonstrate seroconversion of HGE-specific IgM antibodies 1 month after the initial onset of symptoms. According to manufacturer's information, specificity ranged from 97.5% to 100%; sensitivity was 71.4% at 60 days after <italic>A. phagocytophilum</italic> infection. <italic>A. phagocytophilum</italic> IgG antibodies were not detected during follow-up, likely because of prompt treatment with doxycycline.</p>
    <p>Wormser et al. (<xref ref-type="bibr" rid="R5"><italic>5</italic></xref>) suggested that Borrelia-specific antibodies might indicate false-positive results in patients with HGE infection. Our case, however, meets criteria of a newly acquired infection with <italic>B. burgdorferi</italic> sensu lato, with an erythema migrans and seroconversion of <italic>Borrelia</italic>-specific IgM antibodies.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: Loebermann M, Fingerle V, Lademann M, Fritzsche C, Reisinger EC. <italic>Borrelia burgdorferi</italic> and <italic>Anaplasma phagocytophilum</italic> coinfection. Emerg Infect Dis [serial on the Internet]. 2006 Feb [<italic>date cited</italic>]. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid1202.050765">http://dx.doi.org/10.3201/eid1202.050765</ext-link></p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Fingerle</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Goodman</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>RC</given-names></string-name>, <string-name><surname>Kurtti</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Munderloh</surname>
<given-names>UG</given-names></string-name>, <string-name><surname>Wilske</surname>
<given-names>B</given-names></string-name>
<article-title>Human granulocytic ehrlichiosis in southern Germany: Increased seroprevalence in high-risk groups.</article-title>
<source>J Clin Microbiol</source>. <year>1997</year>;<volume>35</volume>:<fpage>3244</fpage>&#x2013;<lpage>7</lpage><pub-id pub-id-type="pmid">9399527</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Lotric-Furlan</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Petrovec</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Avsic-Zupanc</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Nicholson</surname>
<given-names>WL</given-names></string-name>, <string-name><surname>Sumner</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Childs</surname>
<given-names>JE</given-names></string-name>, <etal/>
<article-title>Prospective assessment of the etiology of acute febrile illness after a tick bite in Slovenia.</article-title>
<source>Clin Infect Dis</source>. <year>2001</year>;<volume>33</volume>:<fpage>503</fpage>&#x2013;<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1086/322586</pub-id><pub-id pub-id-type="pmid">11462187</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="book"><string-name><surname>Weber</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Neupert</surname>
<given-names>U</given-names></string-name>, <string-name><surname>B&#xFC;chner</surname>
<given-names>SA</given-names></string-name> Erythema migrans and early signs and symptoms. In: Weber K, Burgdorfer W, editors. Aspects of Lyme borreliosis. Berlin: Springer; <year>1993</year> p.105&#x2013;22.</mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Huppertz</surname>
<given-names>HI</given-names></string-name>, <string-name><surname>B&#xF6;hme</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Standaert</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Karch</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Plotkin</surname>
<given-names>SA</given-names></string-name>
<article-title>Incidence of Lyme borreliosis in the W&#xFC;rzburg region of Germany.</article-title>
<source>Eur J Clin Microbiol Infect Dis</source>. <year>1999</year>;<volume>18</volume>:<fpage>697</fpage>&#x2013;<lpage>703</lpage>
<pub-id pub-id-type="doi">10.1007/s100960050381</pub-id><pub-id pub-id-type="pmid">10584895</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Wormser</surname>
<given-names>GP</given-names></string-name>, <string-name><surname>Horowitz</surname>
<given-names>HW</given-names></string-name>, <string-name><surname>Dumer</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Schwartz</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Aguero-Rosenfeld</surname>
<given-names>M</given-names></string-name>
<article-title>False-positive Lyme disease serology in human granulocytic ehrlichiosis.</article-title>
<source>Lancet</source>. <year>1996</year>;<volume>347</volume>:<fpage>981</fpage>&#x2013;<lpage>2</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(96)91475-0</pub-id><pub-id pub-id-type="pmid">8598802</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
